Carla Dalmaz

Dr. Carla Dalmaz


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2014 in Current Neuropharmacology
Verified
Journal Article
Open access
RKR. Krolow
R. Krolow
DAD. M. Arcego
D. M. Arcego
CNC. Noschang
C. Noschang
SWS. N. Weis
S. N. Weis
CDCarla Dalmaz
Carla Dalmaz
The oxidative imbalance appears to have an important role in anxiety development. Studies in both humans and animals have shown a strong correlation between anxiety and oxidative stress. In humans, for example, the increased malondialdehyde levels and discrepancies in antioxidant enzymes in erythrocytes have been observed. In animals, several studies also show that anxiety-like behavior is related to the oxidative imbalance. Moreover, anxiety-like behavior can be caused by pharmacological-induced oxidative stress. Studies using knockout or overexpression of antioxidant enzymes have shown a relationship between anxiety-like behavior and oxidative stress. Related factors of oxidative stress that could influence anxious behavior are revised, including impaired function of different mitochondrial proteins, inflammatory cytokines, and neurotrophic factors. It has been suggested that a therapy specifically focus in reducing reactive species production may have a beneficial effect in reducing anxiety. However, the neurobiological pathways underlying the effect of oxidative stress on anxiety symptoms are not fully comprehended. The challenge now is to identify the oxidative stress mechanisms likely to be involved in the induction of anxiety symptoms. Understanding these pathways could help to clarify the neurobiology of the anxiety disorder and provide tools for new discovery in therapies and preventive strategies.

18 August 2010 in Neurochemical Research
Verified
Journal Article
Closed access
PDF file
LCLeonardo Crema
Leonardo Crema
MSMichele Schlabitz
Michele Schlabitz
BTBárbara Tagliari
Bárbara Tagliari
ACAline Cunha
Aline Cunha
FSFabrício Simão
Fabrício Simão
CDCarla Dalmaz
Carla Dalmaz

5 March 2014 in Lipids in Health and Disease
Verified
Journal Article
Open access
PDF file
Charles Francisco FerreiraCharles Francisco Ferreira
Charles Francisco Ferreira
JBJuliana Bernardi
Juliana Bernardi
VBVera Lúcia Bosa
Vera Lúcia Bosa
ISIlaine Schuch
Ilaine Schuch
MGMarcelo Zubaran Goldani
Marcelo Zubaran Goldani
PSPatrícia Pelufo Silveira
Patrícia Pelufo Silveira
Although several studies have reported an association between mental disorders and serum levels of brain-derived neurotrophic factor (BDNF), this association is still poorly understood. The study of factors associated with both BDNF levels and mental disorders, such as n-3 polyunsaturated fatty acids (n-3 PUFAs), may help to elucidate the mechanisms mediating the relationship between the two variables. Therefore, the present study aimed to evaluate whether the intake n-3 PUFAs correlates with serum levels of BDNF. This study involved 137 adolescents drawn from a community sample, including a group with high levels of anxiety, assessed using the Screen for Children and Anxiety Related Emotional Disorders. Blood samples were collected and serum BDNF levels were measured. n-3 PUFAs were estimated using a food frequency questionnaire for adolescents. Correlations were performed to assess the association between n-3 PUFAs intake and BDNF levels. Effects of potential confounders (total fat consumption, age, gender and anxiety) were examined using linear regression models. There was a direct correlation between n-3 PUFAs consumption and serum BDNF levels, which remained significant even after accounting for potential confounders. We were able to detect a correlation between n-3 PUFAs intake and peripheral BDNF levels. Our study was limited by its small sample size, and our external validity may be restricted by the oversampling of anxious adolescents. Our findings may help determine the nature of the association between mental disorders and serum levels of BDNF. However, more studies are needed to elucidate the possible mechanisms by which n-3 PUFAs intake affects BDNF levels, and how this may lead to an increased vulnerability to psychiatric disorders.

6 April 2010 in Neurochemical Research
Verified
Journal Article
Closed access
PDF file
CNCristie Grazziotin Noschang
Cristie Grazziotin Noschang
RKRachel Krolow
Rachel Krolow
FFFernanda Urruth Fontella
Fernanda Urruth Fontella
DADanusa M. Arcego
Danusa M. Arcego
LDLuísa Amália Diehl
Luísa Amália Diehl
CDCarla Dalmaz
Carla Dalmaz

11 February 2012 in Neurochemical Research
Verified
Journal Article
Closed access
PDF file
RKR. Krolow
R. Krolow
CNC. Noschang
C. Noschang
SWS. N. Weis
S. N. Weis
LPL. F. Pettenuzzo
L. F. Pettenuzzo
AHA. P. Huffell
A. P. Huffell
CDCarla Dalmaz
Carla Dalmaz

1 August 2015 in Neurochemical Research
Verified
Journal Article
Closed access
PDF file
Charles Francisco FerreiraCharles Francisco Ferreira
Charles Francisco Ferreira
JBJuliana Bernardi
Juliana Bernardi
DSDiego Carrilho da Silva
Diego Carrilho da Silva
NPNatividade Couto Pereira
Natividade Couto Pereira
CMCarina de Souza Mota
Carina de Souza Mota
CDCarla Dalmaz
Carla Dalmaz